Claritev Corporation filings document a healthcare technology, data and insights issuer with Class A common stock listed on the NYSE under CTEV. Its Form 8-K reports furnish operating results, financial-condition updates, investor presentations and Regulation FD materials tied to its analytics, AI and claims-based healthcare cost-management platform.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation, stockholder votes and amendments to the Claritev Corporation 2020 Omnibus Incentive Plan. Other material-event reports address share-repurchase authorization, capital-structure matters and governance transitions.
Claritev Corp (CTEV) was the issuer in reports of two indirect purchases of its Class A common stock by Ares Management LLC, ASOF II Holdings I, L.P., ASOF II A (DE) Holdings I, L.P., and ASOF III Holdings I LP, each identified as a ten percent owner: 50,000 shares on October 23, 2026, at $23.5328 per share, and 20,834 shares on October 26, 2026, at $24.0696 per share. No Rule 10b5-1 plan is reported.
Footnotes state that 70,834 shares were held by ASOF III Holdings I LP and that related entities may be deemed to share beneficial ownership while disclaiming securities not held of record. Ares Partners is managed by a board of managers including Michael J Arougheti, R. Kipp deVeer, David B. Kaplan, Antony P. Ressler, and Bennett Rosenthal; Ressler generally has veto authority over the board's decisions.
Claritev Corp (CTEV) Class A common stock was indirectly purchased in two transactions reported by Ares-related entities: 50,000 shares on October 23, 2026, at $23.5328 per share, and 20,834 shares on October 26, 2026, at $24.0696 per share. The ownership footnote identifies three Ares holder entities and says other listed entities may be deemed to share beneficial ownership, while disclaiming securities not held of record. No Rule 10b5-1 plan is reported.
Claritev Corp (CTEV) director Jennifer Elizabeth Main acquired 3,113 shares of Class A common stock on October 15, 2026, through a pro-rata grant of restricted stock units based on her Board appointment date. Her reported direct holding after the transaction was 3,113 shares. The units vest on the earlier of April 29, 2027, and Claritev’s 2027 annual meeting of stockholders, subject to continued service. In the stated voluntary-resignation circumstance, vesting is pro rata based on days of service.
Claritev Corp's SVP, Chief Growth Officer, Tiffani Misencik, reported selling 5,812 Class A common shares on October 15, 2026, at a weighted average price of $23.8111 per share under a Rule 10b5-1 plan. The reported sale prices ranged from $23.0800 to $24.0800 per share, inclusive. On October 14, 2026, 9,994 shares were withheld to pay taxes applicable to vesting of restricted stock units.
Claritev Corp (CTEV) officer Tiffani Misencik reported a proposed sale of 5,812 common shares, with an estimated aggregate market value of $139,139.28 and an approximate sale date of October 15, 2026. The shares are listed as acquired from Claritev through restricted stock units on October 14, 2026; Morgan Stanley Smith Barney LLC is named as broker, and NYSE as the exchange. Misencik also reported selling 8,850 common shares on August 14, 2026, for gross proceeds of $354,592.95.
Claritev Corporation increased its board from 11 to 12 directors on October 15, 2026, and appointed Jennifer Main as a Class II director and Audit Committee member. Concurrently, Jason Kap ceased serving as an Audit Committee member. Main will receive compensation under the company’s non-employee director compensation policy and enter into its standard form indemnification agreement.
Claritev Corp (CTEV) is the issuer named in an amended ownership report stating that GIC Private Limited, GIC Special Investments Private Limited and Viggo Investment Pte. Ltd. each beneficially own 0 shares of Class A common stock, or 0% of the class. Each entity lists zero sole and shared voting power and zero sole and shared dispositive power. GIC Special Investments is wholly owned by GIC Private Limited; Viggo shares voting and dispositive power over shares it holds directly with both GIC entities.
Claritev Corp (CTEV) reported that EVP and CFO Garis Douglas Michael sold a total of 9,025 shares of Class A common stock on September 21, 2026 in open-market transactions at weighted average prices around $30.50 and $31.19, pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2026. The filing also lists indirect holdings in several Individual Retirement Accounts, including 45,810 shares in the reporting person's IRA and 19,927 shares in the spouse's IRA.
Claritev Corp (CTEV) has a notice indicating that Douglas Garis plans to sell common stock under Rule 144. The filing lists 9,025 shares of common stock to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services in New York, with the shares linked to restricted stock units.